Yuehan Zhang1, Gypsyamber D'Souza1,2, Carole Fakhry1,2, Elaine O Bigelow2, Mykhaylo Usyk3,4,5, Robert D Burk3,4,5,6, Ni Zhao7. 1. Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA. 2. Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University, Baltimore, Maryland, USA. 3. Department of Pediatrics, Albert Einstein College of Medicine, Bronx, New York, USA. 4. Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA. 5. Department of Obstetrics and Gynecology and Women's Health, Albert Einstein College of Medicine, Bronx, New York, USA. 6. Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York, USA. 7. Department of Biostatistics, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
Abstract
BACKGROUND: Although cervicovaginal microbiome has been associated with cervical human papillomavirus (HPV) infection, little is known regarding the association of oral microbiome with oral HPV, a cause of oropharyngeal cancer. METHODS: A cross-sectional analysis of 495 participants from the Men and Women Offering Understanding of Throat HPV study was conducted. 16S rRNA gene amplicon sequencing was performed on saliva samples. HPV DNA in oral rinse samples was tested. Associations of oral microbiome diversity, taxon abundance, and predicted functional pathways with oral HPV were assessed, adjusting for age, race/ethnicity, education, human immunodeficiency virus, current smoking, and sequencing batch. RESULTS: Participants with oral HPV (n = 68) compared with those without HPV had similar oral microbiome alpha-diversity yet different beta-diversity (Bray-Curtis distance for bacterial taxa, P = .009; functional pathways, P = .02). Participants with oral HPV had higher abundance of Actinomycetaceae, Prevotellaceae, Veillonellaceae, Campylobacteraceae, Bacteroidetes, and lower abundance of Gemellaceae (false discovery rate <0.10). We also found differential functional potential of oral microbiome by oral HPV status: xenobiotic biodegradation-related pathways were less abundant among participants with oral HPV, suggesting potential xenobiotic-induced toxic effects with implications for HPV susceptibility. CONCLUSIONS: Our findings suggest a shift in oral microbiome community structure, composition, and functional potential between individuals with and without oral HPV.
BACKGROUND: Although cervicovaginal microbiome has been associated with cervical human papillomavirus (HPV) infection, little is known regarding the association of oral microbiome with oral HPV, a cause of oropharyngeal cancer. METHODS: A cross-sectional analysis of 495 participants from the Men and Women Offering Understanding of Throat HPV study was conducted. 16S rRNA gene amplicon sequencing was performed on saliva samples. HPV DNA in oral rinse samples was tested. Associations of oral microbiome diversity, taxon abundance, and predicted functional pathways with oral HPV were assessed, adjusting for age, race/ethnicity, education, human immunodeficiency virus, current smoking, and sequencing batch. RESULTS: Participants with oral HPV (n = 68) compared with those without HPV had similar oral microbiome alpha-diversity yet different beta-diversity (Bray-Curtis distance for bacterial taxa, P = .009; functional pathways, P = .02). Participants with oral HPV had higher abundance of Actinomycetaceae, Prevotellaceae, Veillonellaceae, Campylobacteraceae, Bacteroidetes, and lower abundance of Gemellaceae (false discovery rate <0.10). We also found differential functional potential of oral microbiome by oral HPV status: xenobiotic biodegradation-related pathways were less abundant among participants with oral HPV, suggesting potential xenobiotic-induced toxic effects with implications for HPV susceptibility. CONCLUSIONS: Our findings suggest a shift in oral microbiome community structure, composition, and functional potential between individuals with and without oral HPV.
Authors: Divya Gopinath; Rohit Kunnath Menon; Moinak Banerjee; Richard Su Yuxiong; Michael George Botelho; Newell W Johnson Journal: Crit Rev Oncol Hematol Date: 2019-04-27 Impact factor: 6.312
Authors: Anil K Chaturvedi; Eric A Engels; Ruth M Pfeiffer; Brenda Y Hernandez; Weihong Xiao; Esther Kim; Bo Jiang; Marc T Goodman; Maria Sibug-Saber; Wendy Cozen; Lihua Liu; Charles F Lynch; Nicolas Wentzensen; Richard C Jordan; Sean Altekruse; William F Anderson; Philip S Rosenberg; Maura L Gillison Journal: J Clin Oncol Date: 2011-10-03 Impact factor: 44.544
Authors: Laura L Reimers; Supriya D Mehta; L Stewart Massad; Robert D Burk; Xianhong Xie; Jacques Ravel; Mardge H Cohen; Joel M Palefsky; Kathleen M Weber; Xiaonan Xue; Kathryn Anastos; Howard Minkoff; Jessica Atrio; Gypsyamber D'Souza; Qian Ye; Christine Colie; Christine P Zolnik; Gregory T Spear; Howard D Strickler Journal: J Infect Dis Date: 2016-08-11 Impact factor: 5.226
Authors: Yanjiao Zhou; Hongyu Gao; Kathie A Mihindukulasuriya; Patricio S La Rosa; Kristine M Wylie; Tatiana Vishnivetskaya; Mircea Podar; Barb Warner; Phillip I Tarr; David E Nelson; J Dennis Fortenberry; Martin J Holland; Sarah E Burr; William D Shannon; Erica Sodergren; George M Weinstock Journal: Genome Biol Date: 2013-01-14 Impact factor: 13.583
Authors: Wodan Ling; Jiuyao Lu; Ni Zhao; Anju Lulla; Anna M Plantinga; Weijia Fu; Angela Zhang; Hongjiao Liu; Hoseung Song; Zhigang Li; Jun Chen; Timothy W Randolph; Wei Li A Koay; James R White; Lenore J Launer; Anthony A Fodor; Katie A Meyer; Michael C Wu Journal: Nat Commun Date: 2022-09-15 Impact factor: 17.694